Sarissa Biomedical Overview
- Year Founded
-
2002
- Status
-
Acquired/Merged
- Employees
-
15
- Latest Deal Type
-
M&A
- Investors
-
1
Sarissa Biomedical General Information
Description
Manufacturer and developer of a hand-held point-of-care diagnostic device designed to identify people who are having a stroke. The company's device is a point-of-care test that uses finger-prick blood samples which are then directed, monitored, and controlled by software, enabling healthcare providers to use them in the measurement of the purines and other neurochemicals, as indicators of neurological activity or disorders.
Contact Information
Website
www.sarissa-biomedical.comCorporate Office
- C/O James Cowper Kreston, 1-4 Cumberland Place
- The White Building
- Southampton SO15 2NP
- England, United Kingdom
Corporate Office
- C/O James Cowper Kreston, 1-4 Cumberland Place
- The White Building
- Southampton SO15 2NP
- England, United Kingdom
Sarissa Biomedical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 16. Merger/Acquisition | 28-May-2021 | Completed | Generating Revenue | |||
| 15. Later Stage VC | 20-May-2020 | Completed | Generating Revenue | |||
| 14. Later Stage VC | 08-Mar-2019 | Completed | Generating Revenue | |||
| 13. Grant | 17-May-2018 | Completed | Generating Revenue | |||
| 12. Later Stage VC | 12-Dec-2017 | Completed | Generating Revenue | |||
| 11. Later Stage VC | 31-Mar-2017 | Completed | Generating Revenue | |||
| 10. Grant | 04-Jul-2016 | Completed | Generating Revenue | |||
| 9. Grant | 01-Mar-2016 | Completed | Startup | |||
| 8. Later Stage VC | 22-Dec-2015 | $238K | $1.39M | Completed | Startup | |
| 7. Grant | 01-Oct-2014 | $24.4K | $1.15M | Completed | Startup |
Sarissa Biomedical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A Ordinary | ||||||||
| A Ordinary | ||||||||
| A Ordinary | ||||||||
| A Ordinary | ||||||||
| A Ordinary | 128,138 | $0.012348 | $2.73 | $2.73 | 1x | $2.73 | 12.88% | |
| Preference | 84,779 | $0.012348 | $2.73 | $2.73 | 1x | $2.73 | 8.52% |
Sarissa Biomedical Comparisons
Industry
Financing
Details
Sarissa Biomedical Competitors (1)
One of Sarissa Biomedical’s competitors is Boston Scientific, a Corporation company based in Marlborough, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Boston Scientific | Corporation | Marlborough, MA |
Sarissa Biomedical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Sarissa Biomedical Patents
Sarissa Biomedical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-201614893-D0 | Apparatus and methods for measuring biological analytes in a liquid | Inactive | 02-Sep-2016 | ||
| US-20180155754-A1 | Methods and devices to detect the presence of a condition associated with atp depletion in a subject | Active | 09-Jun-2015 | ||
| GB-201509974-D0 | Methods and device to detect the presence of ischaemia in a subject | Inactive | 09-Jun-2015 | ||
| US-10889846-B2 | Methods and devices to detect the presence of a condition associated with atp depletion in a subject | Inactive | 09-Jun-2015 | ||
| GB-201509973-D0 | Methods and devices to detect stroke in a subject | Inactive | 09-Jun-2015 | C12Q1/005 |
Sarissa Biomedical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Sarissa Biomedical Former Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Advantage West Midlands | Government | |||
| EarlyStage.nyc Fund | Venture Capital | Minority | ||
| Horizon 2020 | Government | |||
| Innovate UK | Government | |||
| Mercia Asset Management | PE/Buyout | Minority |
Sarissa Biomedical FAQs
-
When was Sarissa Biomedical founded?
Sarissa Biomedical was founded in 2002.
-
Where is Sarissa Biomedical headquartered?
Sarissa Biomedical is headquartered in Southampton, United Kingdom.
-
What is the size of Sarissa Biomedical?
Sarissa Biomedical has 15 total employees.
-
What industry is Sarissa Biomedical in?
Sarissa Biomedical’s primary industry is Diagnostic Equipment.
-
Is Sarissa Biomedical a private or public company?
Sarissa Biomedical is a Private company.
-
What is Sarissa Biomedical’s current revenue?
The current revenue for Sarissa Biomedical is .
-
How much funding has Sarissa Biomedical raised over time?
Sarissa Biomedical has raised $4.93M.
-
Who are Sarissa Biomedical’s investors?
Advantage West Midlands, EarlyStage.nyc Fund, Horizon 2020, Innovate UK, and Mercia Asset Management are 5 of 12 investors who have invested in Sarissa Biomedical.
-
Who are Sarissa Biomedical’s competitors?
Boston Scientific is a competitor of Sarissa Biomedical.
-
When was Sarissa Biomedical acquired?
Sarissa Biomedical was acquired on 28-May-2021.
-
Who acquired Sarissa Biomedical?
Sarissa Biomedical was acquired by Zimmer & Peacock.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
